The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
Servicios
27/08/2020 10:00:00
73000000-2 Research and development services and related consultancy services
73110000-6 Research services
73200000-4 Research and development consultancy services
79311400-1 Economic research services
71620000-0 Analysis services
66170000-2 Financial consultancy, financial transaction processing and clearing-house services
Anuncio | [DispatchDate] |
---|---|
[TNV3F02ContractNotice] (TenderNed) | 29/04/2020 16:00 |
![]() |
24/06/2020 13:23 |
[TNV3F03ContractAwardNotice] (TenderNed) | 21/07/2021 16:30 |